M A Andrykowski, R K Munn, J L Studts. Prev Med 1996
Times Cited: 112
Times Cited: 112
Times Cited
Times Co-cited
Similarity
Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population.
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
E S Tambor, B K Rimer, T S Strigo. Am J Med Genet 1997
46
Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
45
Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
42
Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
40
Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
39
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
38
Interest in genetic testing for colon cancer susceptibility: cognitive and emotional correlates.
R T Croyle, C Lerman. Prev Med 1993
R T Croyle, C Lerman. Prev Med 1993
35
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
32
Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
32
Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
29
Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
29
Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
31
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
26
Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
23
Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
47
A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
S C Daw, C Taylor, M Kraman, K Call, J Mao, S Schuffenhauer, T Meitinger, T Lipson, J Goodship, P Scambler. Nat Genet 1996
S C Daw, C Taylor, M Kraman, K Call, J Mao, S Schuffenhauer, T Meitinger, T Lipson, J Goodship, P Scambler. Nat Genet 1996
20
Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
D A Driscoll, J Salvin, B Sellinger, M L Budarf, D M McDonald-McGinn, E H Zackai, B S Emanuel. J Med Genet 1993
D A Driscoll, J Salvin, B Sellinger, M L Budarf, D M McDonald-McGinn, E H Zackai, B S Emanuel. J Med Genet 1993
20
Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome.
L Edelmann, R K Pandita, B E Morrow. Am J Hum Genet 1999
L Edelmann, R K Pandita, B E Morrow. Am J Hum Genet 1999
20
Molecular definition of 22q11 deletions in 151 velo-cardio-facial syndrome patients.
C Carlson, H Sirotkin, R Pandita, R Goldberg, J McKie, R Wadey, S R Patanjali, S M Weissman, K Anyane-Yeboa, D Warburton,[...]. Am J Hum Genet 1997
C Carlson, H Sirotkin, R Pandita, R Goldberg, J McKie, R Wadey, S R Patanjali, S M Weissman, K Anyane-Yeboa, D Warburton,[...]. Am J Hum Genet 1997
20
Attitudes toward genetic testing for colon cancer risk.
K R Smith, R T Croyle. Am J Public Health 1995
K R Smith, R T Croyle. Am J Public Health 1995
31
Hereditary cancer risk notification and testing: how interested is the general population?
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
32
Attitudes toward colon cancer gene testing: factors predicting test uptake.
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
17
Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
16
Genetic testing for cancer risk: a population survey on attitudes and intention.
Cornelia M Ulrich, Alan R Kristal, Emily White, Julie R Hunt, Sharon J Durfy, John D Potter. Community Genet 1998
Cornelia M Ulrich, Alan R Kristal, Emily White, Julie R Hunt, Sharon J Durfy, John D Potter. Community Genet 1998
32
The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
16
Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
15
What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing.
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
C Lerman, C Hughes, S J Lemon, D Main, C Snyder, C Durham, S Narod, H T Lynch. J Clin Oncol 1998
15
A descriptive study of BRCA1 testing and reactions to disclosure of test results.
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
15
Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
15
Likelihood of undergoing genetic testing for cancer risk: a population-based study.
K Bosompra, B S Flynn, T Ashikaga, C J Rairikar, J K Worden, L J Solomon. Prev Med 2000
K Bosompra, B S Flynn, T Ashikaga, C J Rairikar, J K Worden, L J Solomon. Prev Med 2000
25
Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer.
I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
I M Lipkus, D Iden, J Terrenoire, J R Feaganes. Cancer Epidemiol Biomarkers Prev 1999
15
Women's interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations.
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
N A Press, Y Yasui, S Reynolds, S J Durfy, W Burke. Am J Med Genet 2001
19
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
14
Mammography adherence and psychological distress among women at risk for breast cancer.
C Lerman, M Daly, C Sands, A Balshem, E Lustbader, T Heggan, L Goldstein, J James, P Engstrom. J Natl Cancer Inst 1993
C Lerman, M Daly, C Sands, A Balshem, E Lustbader, T Heggan, L Goldstein, J James, P Engstrom. J Natl Cancer Inst 1993
14
Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
22
Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
K Glanz, J Grove, C Lerman, C Gotay, L Le Marchand. Cancer Epidemiol Biomarkers Prev 1999
14
Attitudes toward colon cancer gene testing: survey of relatives of colon cancer patients.
G M Petersen, E Larkin, A M Codori, C Y Wang, S V Booker, J Bacon, F M Giardiello, P A Boyd. Cancer Epidemiol Biomarkers Prev 1999
G M Petersen, E Larkin, A M Codori, C Y Wang, S V Booker, J Bacon, F M Giardiello, P A Boyd. Cancer Epidemiol Biomarkers Prev 1999
23
Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
13
Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
D Ford, D F Easton, D T Bishop, S A Narod, D E Goldgar. Lancet 1994
13
Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?
J Audrain, B Rimer, D Cella, J Garber, B N Peshkin, J Ellis, J Schildkraut, M Stefanek, V Vogel, C Lerman. J Clin Oncol 1998
J Audrain, B Rimer, D Cella, J Garber, B N Peshkin, J Ellis, J Schildkraut, M Stefanek, V Vogel, C Lerman. J Clin Oncol 1998
19
Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer.
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
28
Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
12
Intention to learn results of genetic testing for hereditary colon cancer.
S W Vernon, E R Gritz, S K Peterson, C A Perz, S Marani, C I Amos, W F Baile. Cancer Epidemiol Biomarkers Prev 1999
S W Vernon, E R Gritz, S K Peterson, C A Perz, S Marani, C I Amos, W F Baile. Cancer Epidemiol Biomarkers Prev 1999
16
Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
C Lerman, B Trock, B K Rimer, C Jepson, D Brody, A Boyce. Health Psychol 1991
12
Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
. J Clin Oncol 1996
. J Clin Oncol 1996
12
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994
12
Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
12
Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
G Geller, T Doksum, B A Bernhardt, S A Metz. Cancer Epidemiol Biomarkers Prev 1999
G Geller, T Doksum, B A Bernhardt, S A Metz. Cancer Epidemiol Biomarkers Prev 1999
18
Genetic testing for colon cancer susceptibility: Anticipated reactions of patients and challenges to providers.
C Lerman, J Marshall, J Audrain, A Gomez-Caminero. Int J Cancer 1996
C Lerman, J Marshall, J Audrain, A Gomez-Caminero. Int J Cancer 1996
12
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.
D F Easton, D T Bishop, D Ford, G P Crockford. Am J Hum Genet 1993
D F Easton, D T Bishop, D Ford, G P Crockford. Am J Hum Genet 1993
11
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.